Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Shares Outstanding (2020 - 2025)

Celularity (CELU) has disclosed Shares Outstanding for 6 consecutive years, with $28.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Shares Outstanding rose 28.35% to $28.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $28.2 million, a 28.35% increase, with the full-year FY2024 number at $22.5 million, up 16.35% from a year prior.
  • Shares Outstanding was $28.2 million for Q3 2025 at Celularity, up from $24.6 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $144.5 million in Q3 2022 to a low of -$90834.0 in Q2 2021.
  • A 5-year average of $43.8 million and a median of $21.9 million in 2024 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: skyrocketed 136022.8% in 2021, then plummeted 88.02% in 2023.
  • Celularity's Shares Outstanding stood at $12.4 million in 2021, then rose by 19.8% to $14.9 million in 2022, then soared by 30.12% to $19.4 million in 2023, then rose by 16.35% to $22.5 million in 2024, then rose by 25.15% to $28.2 million in 2025.
  • Per Business Quant, the three most recent readings for CELU's Shares Outstanding are $28.2 million (Q3 2025), $24.6 million (Q2 2025), and $23.9 million (Q1 2025).